Medicare Enrolled

Dr. Henry Holt, MD

Ophthalmology · Wilmington, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1801 NEW HANOVER MEDICAL PARK DR, Wilmington, NC 28403
9102542023
In practice since 2011 (14 years)
NPI: 1417237884 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holt

Dr. Henry Holt is an ophthalmology specialist in Wilmington, NC, with 14 years of NPI registration. Based on federal Medicare data, Dr. Holt performed 32,264 Medicare services across 3,647 unique beneficiaries.

Between the years covered by Open Payments, Dr. Holt received a total of $1,765 from 13 pharmaceutical and/or device companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 3% volume in NC $1,765 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32,264
Medicare services
Top 3% in NC for ophthalmology
3,647
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,305 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
23,160 $29 $83
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,344 $29 $110
Aflibercept eye injection (Eylea) 1,960 $690 $2,248
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,513 $83 $973
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,081 $88 $240
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
384 $11 $90
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
311 $62 $150
Injection, ranibizumab, 0.1 mg 295 $182 $1,020
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
259 $157 $500
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
210 $26 $150
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
160 $106 $300
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
85 $2,141 $4,924
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
76 $51 $140
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
66 $33 $230
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
61 $102 $280
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
60 $125 $330
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
59 $95 $220
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
41 $16 $50
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
38 $84 $222
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
31 $181 $1,213
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $40 $90
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
17 $21 $70
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
14 $16 $90
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
13 $656 $4,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,765
Total received (2018-2024)
Avg $252/year across 7 years
Top 43% in NC for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
13
Companies
37
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,232 (69.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$533 (30.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$227
2023
$214
2022
$758
2021
$161
2020
$12
2019
$169
2018
$224

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$176
Genentech USA, Inc.
$51
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Notal Vision, Inc.
$520
Regeneron Healthcare Solutions, Inc.
$282
Bausch & Lomb, a division of Bausch Health US, LLC
$207
Astellas Pharma US Inc
$176
Mallinckrodt Hospital Products Inc.
$153
Genentech USA, Inc.
$131
Bausch & Lomb Americas Inc.
$126
AbbVie, Inc.
$87
Allergan Inc.
$23
Mallinckrodt LLC
$17
Allergan, Inc.
$16
Novartis Pharmaceuticals Corporation
$15
NotalVision
$13
Top 3 companies account for 57.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ENVISTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ForeseeHome · Humira · INFUSE · Izervay · Lucentis · OZURDEX · VABYSMO · Vabysmo · XIPERE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Wilmington?
Compare ophthalmologists in the Wilmington area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
33
Per 100K population
14.3
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
7.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Holt is a mixed practice specialist, with above-average Medicare volume (top 3% in NC), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Holt experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Holt performed 23,160 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Holt receive payments from pharmaceutical companies?
Yes. Dr. Holt received a total of $1,765 from 13 companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holt's costs compare to other ophthalmologists in Wilmington?
Dr. Holt's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →